In a new study, researchers show that one psychedelic, psilocybin, essentially repairs the part of the brain responsible for alcohol cravings, hinting at a potential new treatment for the disorder.
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
In a new study, researchers show that one psychedelic, psilocybin, essentially repairs the part of the brain responsible for alcohol cravings, hinting at a potential new treatment for the disorder.
Digital therapeutics is the key to the rapid commercialization of psychedelic medicine. MINDCURE's iSTRYM digital therapeutics platform is the first-mover in the industry.
Psychedelic companies feel that Compass Pathways results validate efforts to develop next-generation medicine for treating mental health issues.
If these states do move forward with the legalization of adult use recreational cannabis, the fight for the end of nationwide cannabis prohibition could be reaching its finale.
Compass Pathways revealed psychedelic drugs were highly effective as a therapy for treatment-resistant depression.
Psychedelic medicine is both extremely efficacious and highly cost-effective. It is also an absolute necessity to RESCUE the economy.